Should You Invest in 89bio Inc (ETNB) Now?

The 36-month beta value for ETNB is at 1.34. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”

The public float for ETNB is 138.70M, and currently, shorts hold a 6.01% of that float. The average trading volume for ETNB on February 21, 2025 was 2.04M shares.

ETNB) stock’s latest price update

89bio Inc (NASDAQ: ETNB)’s stock price has decreased by -3.01 compared to its previous closing price of 11.30. However, the company has seen a -0.45% decrease in its stock price over the last five trading sessions. zacks.com reported 2025-02-20 that 89BIO (ETNB) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ETNB’s 50-day simple moving average crossed above its 200-day simple moving average, known as a “golden cross.

ETNB’s Market Performance

ETNB’s stock has fallen by -0.45% in the past week, with a monthly rise of 66.57% and a quarterly rise of 38.21%. The volatility ratio for the week is 4.83% while the volatility levels for the last 30 days are 8.79% for 89bio Inc The simple moving average for the last 20 days is 8.40% for ETNB stock, with a simple moving average of 29.73% for the last 200 days.

Analysts’ Opinion of ETNB

BofA Securities, on the other hand, stated in their research note that they expect to see ETNB reach a price target of $30. The rating they have provided for ETNB stocks is “Buy” according to the report published on April 22nd, 2024.

RBC Capital Mkts gave a rating of “Sector Perform” to ETNB, setting the target price at $15 in the report published on January 12th of the previous year.

ETNB Trading at 28.82% from the 50-Day Moving Average

After a stumble in the market that brought ETNB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.10% of loss for the given period.

Volatility was left at 8.79%, however, over the last 30 days, the volatility rate increased by 4.83%, as shares surge +62.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.91% upper at present.

During the last 5 trading sessions, ETNB fell by -0.45%, which changed the moving average for the period of 200-days by +23.70% in comparison to the 20-day moving average, which settled at $10.11. In addition, 89bio Inc saw 40.15% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ETNB starting from RA CAPITAL MANAGEMENT, L.P., who purchase 5,714,285 shares at the price of $8.75 back on Jan 30 ’25. After this action, RA CAPITAL MANAGEMENT, L.P. now owns 19,554,319 shares of 89bio Inc, valued at $49,999,994 using the latest closing price.

McWherter Charles, the Director of 89bio Inc, purchase 10,000 shares at $6.71 during a trade that took place back on Jan 22 ’25, which means that McWherter Charles is holding 25,000 shares at $67,100 based on the most recent closing price.

Stock Fundamentals for ETNB

Current profitability levels for the company are sitting at:

  • -1298.53 for the present operating margin
  • 0.84 for the gross margin

The net margin for 89bio Inc stands at -1234.87. The total capital return value is set at -0.72. Equity return is now at value -73.31, with -62.93 for asset returns.

Based on 89bio Inc (ETNB), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -7.47. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -61.2.

Currently, EBITDA for the company is -134.46 million with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of 6596.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.65.

Conclusion

In conclusion, 89bio Inc (ETNB) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts